Stephen Basil Thomas sold $471K of Climb Bio (CLYM)

Executed Feb 12, disclosed Feb 17, 5 days later.

Value, as filed

$471K

90,000 sh × $5.23

Executed

Feb 12

the trade date, as filed

Disclosed

Feb 17

5 days after the trade

Return, 21 sessionsiFrom the disclosed entry session; derived

–

purchases only

Returns are measured on stock purchases only.

The filer

Stephen Basil Thomas Director profile →

Stephen Basil Thomas (Director) filed 3 Form 4 reports in the trailing twelve months (0 purchases, 3 sales), most often in Climb Bio, Inc. (CLYM). The largest single filing was $1.4M of CLYM (100,000 sh × $13.67, as filed), executed Sep 15.

The name

CLYM

Climb Bio, Inc. CLYM · Healthcare · 5 filings in 24 months ticker →

Healthcare · Climb Bio, Inc., a clinical-stage biotechnology company, focuses on developing therapies to address unmet needs for patients living with im…

More Healthcare filings→ Insider filings, newest first→ View the original filing at www.sec.gov→

Other filings by Stephen Basil Thomas in CLYM

CLYMSALE Climb Bio, Inc. $1.4M
100,000 sh × $13.67
Exec Sep 15
Filed Sep 17 · 4:15 PM ET CLYMSALE Climb Bio, Inc. $350K
50,000 sh across 2 lots
Exec Feb 25
Filed Feb 27 · 5:30 PM ET